BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 32357580)

  • 1. Structure and Function of Human Matrix Metalloproteinases.
    Laronha H; Caldeira J
    Cells; 2020 Apr; 9(5):. PubMed ID: 32357580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
    Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
    J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metalloproteinases: A parade of functions in matrix biology and an outlook for the future.
    Apte SS; Parks WC
    Matrix Biol; 2015; 44-46():1-6. PubMed ID: 25916966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions.
    Varghese S
    Front Biosci; 2006 Sep; 11():2949-66. PubMed ID: 16720367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of TIMPs in regulation of extracellular matrix proteolysis.
    Arpino V; Brock M; Gill SE
    Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis.
    Shan L; Wang F; Zhai D; Meng X; Liu J; Lv X
    Biomed Pharmacother; 2023 May; 161():114472. PubMed ID: 37002573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and Biological Attributes of Matrix Metalloproteinases.
    Cui N; Hu M; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
    Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in hypertension. Pathogenesis of hypertension and obesity].
    Trojanek JB
    Postepy Biochem; 2015; 61(4):356-63. PubMed ID: 27048090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and their inhibitors regulate in vitro ureteric bud branching morphogenesis.
    Pohl M; Sakurai H; Bush KT; Nigam SK
    Am J Physiol Renal Physiol; 2000 Nov; 279(5):F891-900. PubMed ID: 11053050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
    Chen Y; Peng W; Raffetto JD; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion.
    Bourboulia D; Stetler-Stevenson WG
    Semin Cancer Biol; 2010 Jun; 20(3):161-8. PubMed ID: 20470890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
    Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
    Cells; 2020 May; 9(5):. PubMed ID: 32466129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct visualization of protease action on collagen triple helical structure.
    Rosenblum G; Van den Steen PE; Cohen SR; Bitler A; Brand DD; Opdenakker G; Sagi I
    PLoS One; 2010 Jun; 5(6):e11043. PubMed ID: 20585385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Role of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Regulation of Matrix Metalloproteinases (MMPs) Expression in Periodontal Diseases.
    Liu N; Zhou B; Zhu G
    Med Sci Monit; 2016 Jun; 22():1936-8. PubMed ID: 27272560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporospatial distribution of matrix metalloproteinase and tissue inhibitors of matrix metalloproteinases during murine secondary palate morphogenesis.
    Morris-Wiman J; Burch H; Basco E
    Anat Embryol (Berl); 2000 Aug; 202(2):129-41. PubMed ID: 10985432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porphyromonas gingivalis affects host collagen degradation by affecting expression, activation, and inhibition of matrix metalloproteinases.
    Zhou J; Windsor LJ
    J Periodontal Res; 2006 Feb; 41(1):47-54. PubMed ID: 16409255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix Metalloproteinases in the Periodontium-Vital in Tissue Turnover and Unfortunate in Periodontitis.
    Radzki D; Negri A; Kusiak A; Obuchowski M
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic-Reperfusion Injury Increases Matrix Metalloproteinases and Tissue Metalloproteinase Inhibitors in Fetal Sheep Brain.
    Chen X; Patra A; Sadowska GB; Stonestreet BS
    Dev Neurosci; 2018; 40(3):234-245. PubMed ID: 30048980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.